Tyler F. Stewart, MD, presented “Point-Counterpoint: Will Conventional Imaging Become Obsolete? – Con” during the 30th Annual Perspectives in Urology: Point-Counterpoint, on March 10, 2023, at Humphreys Half Moon Inn, San Diego, California.
How to cite: Stewart, Tyler F. “Point-Counterpoint: Will Conventional Imaging Become Obsolete? – Con.” March 10, 2023. Accessed May 2024. https://grandroundsinurology.com/point-counterpoint-will-conventional-imaging-become-obsolete-con/
Point-Counterpoint: Will Conventional Imaging Become Obsolete? – Con – Summary
Dr. Tyler F. Stewart, MD, delivers an insightful discussion on the significant role of conventional imaging techniques in the diagnosis and treatment of this complex disease. The transformative impact of PSMA scans on precision and early detection is undeniable, offering promising prospects for improved patient prognosis.
While PSMA scans have emerged as a game-changer in various clinical scenarios, Dr. Stewart acknowledges that conventional imaging still holds value in specific contexts such as active surveillance and metastatic disease. However, he underscores the ongoing research in assessing the full potential of PSMA scans for monitoring metastatic disease, an area that continues to be explored by the scientific community.
To ensure a comprehensive evaluation and the formulation of tailored treatment strategies, Dr. Stewart emphasizes the integration of both PSMA and non-PSMA imaging techniques. By leveraging the strengths of each modality, healthcare providers can optimize diagnostic accuracy, monitor disease progression, and make informed decisions regarding the most appropriate course of action for prostate cancer patients.
This lecture is part of a Point-Counterpoint debate. Its opposing lecture is “Point-Counterpoint: Will Conventional Imaging Become Obsolete?–Pro.”
About the 30th Annual Perspectives in Urology: Point Counterpoint conference: Presented by Program Chair and Grand Rounds in Urology Editor-in-Chief E. David Crawford, MD, this conference brought together leading experts in urology, medical oncology, and radiation oncology to discuss and debate the latest topics in genitourinary cancers, primarily prostate cancer and bladder cancer. This interactive conference offered topical lectures, pro/con debates, interesting-case presentations, interactive panel discussions, and interactive audience and faculty networking.
